Cure My Disease

Don't miss your cure!

 Log in / Sign up

Ultrasound-Guided trigger finger release may speed up recovery

NCT ID NCT07364695

Symptom relief Sponsor: Massachusetts General Hospital Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at two surgical methods for trigger finger: the standard open surgery and a newer ultrasound-guided technique. Researchers wanted to see if the ultrasound-guided method helps people recover faster and have less pain. Sixty adults who needed surgery for trigger finger took part, and their daily activities and pain levels were tracked after the procedure.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

60 people

The number who actually took part.

Started

Jun 2023

Finished

Dec 2024

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

patients undergoing trigger finger release for the index through small fingers was conducted from June 2023 through June 2024 at two tertiary care academic medical centers in an integrated health network

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * undergoing trigger finger release for the index through small fingers due to symptoms refractory to conservative treatment and elected for surgical intervention through shared decision-making * English-speaking adults (≥18 years of age) * Patients with inflammatory arthritis were included if their diagnosis had been established ≥5 years prior without exacerbations in the past 5 years. Those on immunomodulatory therapy were required to have been on a stable regimen for ≥5 years without flare-ups. Exclusion Criteria: * prior surgery on the affected finger * corticosteroid injection in the affected hand within 6 weeks * additional hand or wrist pathology requiring concurrent surgery * symptomatic trigger finger in the contralateral extremity * prior surgical pulley release in either hand within 6 months of enrollment * Systemic inflammatory disease (e.g., rheumatoid arthritis, lupus) not controlled * inflammatory arthritis if diagnosis established \<5 years, exacerbation within the past 5 years, or modifications to immunomodulatory therapy within 5 years of enrollment * Amyloidosis * Diabetes not controlled by a stable dose of medication over the past three months * Pregnant or planning pregnancy in the next 6 months * Workers' compensation subjects * Inability to provide a legally acceptable Informed Consent Form and/or comply with all follow-up requirements, including patients who do not speak English * other medical, social, or psychological conditions that, in the opinion of the investigator, preclude them from receiving the pre-treatment, required treatment, and post-treatment procedures and evaluations. * Trigger Thumb

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Trigger finger are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

trigger thumb

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Trigger finger

Contacts and locations

Locations

  • Brigham and Women's Hospital

    Boston, Massachusetts, 02114, United States

  • Massachusetts General Hospital

    Boston, Massachusetts, 02114, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.